Genomics

Conferences & Courses
Gene Therapy Breakthroughs Gene Therapy Breakthroughs
September 22-23, 2015 | Boston, MA
Protein-Protein Interactions as Drug Targets Conference, part of Discovery on Target 2014 in Boston, explores current PPI targets and new approaches for identifying PPI inhibitors for medical therapies.

RNAi for Functional Genomics Screening RNAi for Functional Genomics Screening
September 22-23, 2015 | Boston, MA
RNAi Screens Functional Genomics Drug Discovery conference/meeting Cambridge Healthtech Institute's tenth annual conference on Functional Genomics Screening Strategies will cover the latest in the use of RNA interference (RNAi) screens, combination (

Targeting the Ubiquitin Proteasome System Targeting the Ubiquitin Proteasome System
September 22-23, 2015 | Boston, MA
It is no surprise that emerging strategies in drug discovery moving away from single-target approaches are shifting toward targeting multicomponent cellular machineries such as the ubiquitin proteasome system (UPS) to elicit therapeutic response in comple




Life Science Media Library
Determining Genome Variation and Clinical Utility DVD Determining Genome Variation and Clinical Utility DVD
April 21, 2015 |
This all-BioTeam workshop will focus on covering the entire array of best practices for converged infrastructure through hardware selection, configuration, software, and data management for life sciences research and clinical environments. BioTeam defines converged infrastructure as the unification of disparate hardware, software, and support personnel into a blended and tuned end-to-end solution that makes it easier for scientists and clinicians to accomplish their data interpretation goals. The agenda of the workshop will focus on presenting and discussing reference designs for networking, storage, HPC, cloud (public and private), and hybrid infrastructures, as well as scientific software installation, maintenance, and development best practices. The course is designed to inform IT organizations and tech-savvy scientists about the methodologies and best practices behind making the datacenter an extension of the laboratory in a manner that enables scientific discovery, rather than forcing science to adapt to IT infrastructure. This intensive 3 ½ hour course will leave you with many ideas for how to better support the scientists and clinicians within your organization.
Next Generation Sequencing Next Generation Sequencing
August 14, 2012 |
If you are confused by the evolving, rapidly changing, and dynamic nature of the Next Generation Sequencing market, then this is the course for you. This course will provide you with a comprehensive, clear outline of the various sequencing technologies currently available, their best suited applications, and which analysis strategies go with what applications in order to get the best answer from the data.
A Practical Guide to Choosing the Right SNP Detection Tool A Practical Guide to Choosing the Right SNP Detection Tool
August 13, 2012 |
There is an urgent need for the NGS community to be able to make the right choice from available SNP detection tools. We have used exome-seq data to evaluate the quality of SNP calls from selected discovery tools from both academic and commercial products. We compared the quality of SNP calls from selected tools side by side and assessed their global quality by checking for Mendelian inheritance inconsistencies within the SNP calls of family members and by using the SNP array data from the same samples. This course will show the comparison results of these selected tools and provide a practical guide to choosing and using the right SNP detection tool.




Publications, Reports, & Whitepapers
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Mgmt
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management report explores the background, history and basic research of liquid biopsy covering the three sample categories that dominate liquid biopsy today: circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs, also known as exosomes). This report also details the commercial aspects, market dynamics, and trends of liquid biopsy.
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective provides an overview of the scientific and technological landscape from which both the diagnostic and therapeutic sectors of the nascent epigenetics industry are emerging, plus a qualitative analysis of the scientific, technological, and commercial achievements and challenges facing both sectors.













CII Offerings
  • PepTalk 2016
  • MMTC16 Icon
  • SCOPE Icon
  • BioITWorld_scroll_81015
  • Drug Discovery Chemistry_scroll_81015
  • PEGS_scroll_81015
  • Biomarkers & Diagnostics World Congress_scroll_81015
  • World Preclinical Congress_scroll_81015
  • Bioprocess Summit_81015
  • Next Generation DX Summit_81015
  • DOT Icon